James A Russell Selected Research

Vasopressins (Vasopressin)

1/2021	Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis.
4/2020	Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.
1/2020	The Specific Organism: Not Bacterial Gram Type: Drives the Inflammatory Response in Septic Shock.
1/2019	Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis.
1/2019	Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis.
1/2019	Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.
11/2018	CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis.
10/2018	Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
1/2018	Is Heparin-Binding Protein Inhibition a Mechanism of Albumin's Efficacy in Human Septic Shock?
1/2018	Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Russell Research Topics

Disease

76	Septic Shock (Toxic Shock Syndrome) 02/2022 - 03/2002
64	Sepsis (Septicemia) 10/2022 - 09/2003
20	Critical Illness (Critically Ill) 01/2022 - 04/2004
18	Shock 02/2022 - 12/2004
17	Infections 10/2022 - 03/2005
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 08/2004
12	Pulmonary Hypertension 03/2012 - 06/2002
10	Inflammation (Inflammations) 01/2018 - 10/2003
6	COVID-19 04/2022 - 12/2020
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2017 - 11/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2010 - 08/2004
5	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 01/2010
5	Leukemia 06/2009 - 02/2006
4	Pre-Eclampsia (Preeclampsia) 07/2018 - 08/2002
4	Hypotension (Low Blood Pressure) 03/2017 - 03/2009
4	Ischemia 01/2017 - 08/2007
3	Stroke (Strokes) 11/2022 - 04/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 08/2007
3	Myocardial Infarction 01/2021 - 04/2003
3	Acute Lung Injury 01/2021 - 04/2003
3	Pneumonia (Pneumonitis) 12/2020 - 09/2005
3	Neoplasms (Cancer) 04/2018 - 07/2003
3	Hematologic Neoplasms (Hematological Malignancy) 09/2013 - 02/2008
3	Necrosis 06/2013 - 08/2004
3	Hyperoxia 03/2012 - 02/2008
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2005 - 08/2002
2	Multiple Organ Failure (MODS) 01/2022 - 01/2017
2	Severe Acute Respiratory Syndrome 01/2021 - 11/2003
2	Human Influenza (Influenza) 01/2021 - 12/2020
2	Edema (Dropsy) 10/2019 - 08/2004
2	Low Cardiac Output 11/2018 - 05/2014
2	Disease Progression 07/2018 - 11/2015
2	Heart Failure 04/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

50	Vasopressins (Vasopressin)IBA 01/2021 - 03/2002
33	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 03/2002
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2003
13	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 10/2004
10	CytokinesIBA 01/2020 - 01/2005
8	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 08/2011
8	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2003
8	fludarabineIBA 02/2012 - 08/2004
7	Protein CIBA 07/2018 - 08/2002
7	Busulfan (Busulfex)FDA Link 12/2011 - 08/2004
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
6	Pharmaceutical PreparationsIBA 01/2021 - 06/2009
6	drotrecogin alfa activated (Xigris)FDA Link 07/2018 - 08/2002
6	AlbuminsIBA 01/2018 - 01/2003
6	thymoglobulin FDA Link 08/2014 - 07/2007
5	LipopolysaccharidesIBA 10/2022 - 05/2007
5	Biological ProductsIBA 01/2022 - 03/2005
5	Proprotein Convertase 9IBA 01/2019 - 12/2015
5	Interleukin-10 (Interleukin 10)IBA 01/2019 - 09/2003
5	human AZU1 proteinIBA 01/2018 - 11/2015
5	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2017 - 03/2012
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2014 - 03/2007
5	CreatinineIBA 05/2014 - 10/2004
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2013 - 12/2006
5	Oxygen (Dioxygen)IBA 04/2012 - 10/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 04/2003
4	LipidsIBA 01/2018 - 10/2014
4	CatecholaminesIBA 03/2017 - 08/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 09/2003
3	Angiotensin Receptor AntagonistsIBA 04/2022 - 07/2021
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 07/2011
3	HDL CholesterolIBA 01/2021 - 01/2017
3	Cholesterol Ester Transfer ProteinsIBA 01/2021 - 11/2018
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2016
3	SteroidsIBA 12/2019 - 10/2004
3	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2019 - 08/2011
3	EndotoxinsIBA 01/2019 - 11/2014
3	EnzymesIBA 12/2017 - 09/2011
3	Interleukin-8 (Interleukin 8)IBA 01/2016 - 09/2006
3	Methotrexate (Mexate)FDA LinkGeneric 09/2013 - 08/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 07/2007
3	ChemokinesIBA 08/2013 - 10/2008
3	Superoxides (Superoxide)IBA 09/2011 - 04/2003
3	Superoxide DismutaseIBA 09/2011 - 12/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2011 - 11/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011 - 09/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 07/2021
2	SodiumIBA 06/2021 - 05/2011
2	BilirubinIBA 01/2021 - 10/2004
2	HDL LipoproteinsIBA 01/2021 - 01/2019
2	AngiotensinsIBA 01/2021 - 12/2020
2	TerlipressinIBA 05/2019 - 08/2012
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 11/2003
2	Crystalloid SolutionsIBA 01/2018 - 08/2004
2	GlucocorticoidsIBA 12/2017 - 12/2017
2	Methylprednisolone FDA LinkGeneric 12/2017 - 12/2017

Therapy/Procedure

31	Therapeutics 02/2022 - 08/2002
18	Critical Care (Surgical Intensive Care) 01/2022 - 11/2003
15	Resuscitation 02/2022 - 01/2003
7	Artificial Respiration (Mechanical Ventilation) 04/2022 - 07/2010
6	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2022 - 01/2010
5	Ligation 01/2021 - 06/2002
5	Stem Cell Transplantation 12/2011 - 06/2006
4	Cell Transplantation 01/2020 - 03/2009
4	Hematopoietic Stem Cell Transplantation 04/2010 - 08/2004
3	Mechanical Ventilators (Ventilator) 10/2019 - 09/2006
3	Transplantation 04/2014 - 10/2004